insights_auto
Why is NZM2 up 4,09%?
Dive Deeperchevron_right
NZM2:ETR
Novozymes A/S
€58,00
arrow_upward
+4,09%(+2,28) 1D
5 ຕ.ລ., 17 ໂມງ 35 ນາທີ 35 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM2...
Open
€56,28
High
€58,00
Low
€56,22
Mkt. cap
172,47 ຕື້
Avg. vol.
136,00
Volume
182,00
52-wk high
€61,96
52-wk low
€46,74
No. of employees
11 ພັນ
Open
€56,28
High
€58,00
Low
€56,22
Mkt. cap
172,47 ຕື້
Avg. vol.
136,00
Volume
182,00
52-wk high
€61,96
52-wk low
€46,74
No. of employees
11 ພັນ
News stories
From web sources and news partners
www.marketscreener.com
·
7 ຊົ່ວໂມງກ່ອນ
Transactions under Novonesis’ share buyback program
Dairy Business Middle East & Africa
·
2 ມື້ກ່ອນ
Novonesis strengthens dairy innovation with facility expansion
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S
CEOEster Baiget
Employees11,1 ພັນ
Founded2000
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com